Renowned Prostate Cancer Robotic Surgeon and Urologist Dr. John K. Burgers Joins Florida Urology Center, an Affiliate of U.S. Urology Partners

Florida Urology Center today announced that John K. Burgers, MD, has joined the practice, bringing three decades of leadership and innovation in advanced robotic surgery and general urologic care to the region. Florida Urology Center is a full-service specialty group providing comprehensive services in five locations throughout Florida, including Ormond Beach, Port Orange, Orange City, New Smyrna Beach and Palm Coast. Florida Urology Center is an affiliate of U.S. Urology Partners, one of the nation’s leading providers of urological services.

An internationally recognized urologist and surgeon, Dr. Burgers has been practicing urology for 30 years and has more than 18 years of robotic surgery experience. He has performed more than 10,000 radical prostatectomies for prostate cancer patients, with excellent results. Dr. Burgers completed his Medical School, Internship and Residency at The Johns Hopkins University School of Medicine. There he trained under the world-famous Dr. Patrick Walsh, the pioneer of the nerve sparing radical prostatectomy. He spent five years as an assistant professor at The James Comprehensive Cancer Center in Columbus, Ohio, where he trained many urology residents and published numerous research articles.

Dr. Greg A. Parr of Florida Urology Center stated, “We are honored to welcome Dr. John Burgers to our care team at Florida Urology Center. In addition to his background in general urology, we are excited about Dr. Burgers’ expertise in leading edge cancer care and robotic surgery for prostate cancer patients. Dr. Burgers will support Florida Urology Center in continuing to provide the most advanced, effective treatments for prostate cancer patients in the communities we serve.“

Dr. John K. Burgers said, “I am thrilled about the opportunity to be joining such a premier urology group as Florida Urology Center, which sets the standard of care in the region. I am impressed with the highly skilled care team at Florida Urology Center and their focus on providing utmost quality patient care in a compassionate, heartwarming environment where I can continue to progress and contribute in my career.”

Dr. Burgers is consistently ranked 5 out of 5 stars by his patients and has received the Top Doctor award in Columbus, Ohio, multiple times. Dr. Burgers comes to Florida Urology Center from Central Ohio Urology Group, a leading urology practice in the Midwest that is also an affiliate practice of U.S. Urology Partners. Dr. Burgers has had a second home in Palm Coast, Florida, for more than 12 years and is an avid golfer with a membership at the Hammock Beach Resort. He and his family love the area and are delighted to bring his expertise to the northeast coast of Florida.

Consultations with Dr. Burgers are currently being scheduled for the Florida Urology Center offices in Palm Coast and Ormond Beach. To schedule an appointment with Dr. Burgers or to refer a patient, please visit www.floridaurology.com or call (386) 673-5100.

About Florida Urology Center

Established in 1992, Florida Urology Center has five convenient locations throughout Florida, including Ormond Beach, Port Orange, Orange City, New Smyrna Beach and Palm Coast. Florida Urology Center is committed to providing quality healthcare to its patients through education, training, clinical research and support. The practice is dedicated to improving the lives of its patients by offering the most current diagnostic and therapeutic alternatives available. Facilities are equipped with the latest state-of-the art technology to provide the safest and most comprehensive care. Most of the surgeries are performed in Florida Urology Center’s outpatient surgery center licensed by the state of Florida and certified by Medicare. For more information about Florida Urology Center, please visit www.floridaurology.com.

About U.S. Urology Partners

U.S. Urology Partners is one of the nation’s largest independent providers of urology and related specialty services, including general urology, surgical and robotic procedures, advanced cancer treatment and other ancillary services. The U.S. Urology Partners clinical network consists of more than 50 locations throughout the East Coast and Midwest. U.S. Urology Partners was formed to support urology practices with an experienced team of healthcare executives and resources, and is backed by NMS Capital. The U.S. Urology Partners corporate office is in Nolensville, Tennessee, just outside of Nashville. For additional information about U.S. Urology Partners, please visit www.us-uro.com.

U.S. Urology Partners First in Region to Provide Minimally Invasive Aquablation Procedure for Enlarged Prostate at Central Ohio Urology Group

Half of all men over the age of 50 struggle with a decreased quality of life due to benign prostatic hyperplasia (BPH), also known as enlarged prostate. At Central Ohio Urology Group, an affiliate of U.S. Urology Partners, an innovative, minimally invasive procedure called Aquablation is changing that for patients. Dr. Scott D. Barkin of Central Ohio Urology Group is one of the most experienced Aquablation experts in Ohio and surrounding states, and has performed the procedure for more than 100 patients.

BPH is a non-cancerous condition where the prostate has grown to be larger than normal. One in two men between the ages of 51 and 60 have BPH, and the incidence increases each decade of life such that by age 80, 90% of men will have BPH.* If left untreated, BPH can cause significant health problems, including irreversible bladder or kidney damage, bladder stones, UTIs and incontinence, as well as inability or difficulty urinating, or urinating often.

Aquablation therapy combines real-time, multi-dimensional imaging, automated robotic technology and heat-free waterjet ablation for targeted, controlled and immediate removal of prostate tissue. Because there isn’t heat involved with the treatment, Aquablation has less effect on the structures around the prostate, helping to preserve sexual function in most patients.

“Improved quality of life is the key benefit for our BPH patients,” says Dr. Scott D. Barkin of Central Ohio Urology Group, an affiliate of U.S. Urology Partners. “Typically, our patients are seeking better urination by removing an existing indwelling catheter, eliminating their prostate medication or achieving a better night’s sleep with fewer trips to the restroom. When compared with similar treatments for BPH, Aquablation tries to spare the men’s ejaculatory function, removes more prostate tissue in a shorter time and therefore requires less anesthesia, and is only one of a few treatments designed for large prostates.”

Aquablation therapy, like similar therapies for large prostates, is performed in a hospital and is done under anesthesia. The procedure typically takes around 60 to 90 minutes (less for smaller prostates; more for larger prostates) and may involve an overnight stay depending on the size of the prostate. No incision is necessary, as the prostate is reached through the urethra.

Other BPH surgical treatments often force men to compromise between symptom relief and side effects. Patients choosing a high degree of symptom relief face possible complications such as incontinence, erectile dysfunction or ejaculatory dysfunction.

Central Ohio Urology Group physicians performing Aquablation therapy include Dr. Scott D. Barkin, Dr. William E. Bloch and Dr. Adam C. Weiser. To discuss treatment options for BPH, contact the group at 614.396.2684.

About U.S. Urology Partners

U.S. Urology Partners is one of the nation’s largest independent providers of urology and related specialty services, including general urology, surgical and robotic procedures, advanced cancer treatment  and other ancillary services. The U.S. Urology Partners clinical network consists of more than 50 locations throughout the East Coast and Midwest. U.S. Urology Partners was formed to support urology practices with an experienced team of healthcare executives and resources, and is backed by NMS Capital. The U.S. Urology Partners corporate office is in Nolensville, Tennessee, just outside of Nashville. For additional information about U.S. Urology Partners, please visit www.us-uro.com.

EndoTheia Inc. Announces FDA Breakthrough Device Designation for Technology to Improve Endoscopic Surgery

EndoTheia Inc., a Nashville-based medical device company, announced today that it has gained priority status from the FDA by receiving a Breakthrough Device designation from the agency for its technology that radically improves minimally invasive flexible endoscopic surgery. It is only the seventh device in the category of Ear Nose and Throat (ENT) devices to ever receive this designation. The designation will streamline the regulatory process, enabling EndoTheia to rapidly bring its innovative solution to doctors and patients.

EndoTheia’s Breakthrough Device leverages foundational technology that was originally invented at Vanderbilt and the University of Tennessee. This technology, based on extremely thin-walled, laser-machined metallic tubes, enables the creation of highly flexible, steerable devices that can pass through standard endoscopes, while also carrying within themselves interventional tools. The steerability that these devices provide to endoscope-delivered tools opens the door for new diagnostic and therapeutic applications of flexible endoscopy. EndoTheia’s disruptive platform technology can be used across a vast array of clinical specialties, including urology, gastroenterology, neurology, and otology.

“EndoTheia was founded in 2018 to develop the next generation of medical devices for flexible endoscopy with the goal of increasing effectiveness through added flexibility and dexterity,” stated Robert J. Webster, III, PhD, Co-Founder and President of EndoTheia. “EndoTheia’s technology is currently the only viable option to add dexterity to flexible endoscopy, without re-engineering the endoscope itself. This empowers surgeons to provide much more accurate and precise therapeutic interventions in a wide range of clinical specialties.” The National Institutes of Health has corroborated this sentiment by providing millions of dollars of grant funding to EndoTheia to commercialize products in urology, gastroenterology, and otolaryngology.

Duke Herrell, III, MD, FACS, Co-Founder and Chief Medical Officer of EndoTheia, added, “We are excited that the FDA has recognized the huge potential of EndoTheia’s technology through Breakthrough Device designation. The FDA has affirmed our view that there is nothing else out there capable of doing what we do for flexible endoscopy, and that our technology represents a breakthrough treatment option for patients who currently face irreversibly debilitating disease.”

EndoTheia’s team of internationally recognized clinical and engineering experts includes Dr. Webster and Dr. Herrell, along with Joshua Gafford, PhD, Chief Technical Officer, and Caleb Rucker, PhD, Chief Scientific Officer and primary inventor of the Company’s underlying technology. Drs. Webster and Herrell, along with others, co-founded the Vanderbilt Institute for Surgery and Engineering (VISE), and Dr. Rucker leads the REACH Robotics Lab at the University of Tennessee, Knoxville. Dr. Gafford has been the leading the internal development and commercialization efforts at EndoTheia since the Company’s incorporation in 2018.

EndoTheia has demonstrated feasibility in animal, cadaver, and tissue model studies in surgeries for biliary disease, ureteroscopy kidney stone removal, endoscopic submucosal dissection (ESD), endoscopic neurosurgery, sinus surgery, and middle ear surgery. EndoTheia’s technology can provide dexterity in any procedures where tools are delivered through flexible endoscopes, including urology, neurology, interventional pulmonology, gastroenterology, colorectal, orthopedics, otolaryngology (ENT), and other sub-specialties.

About EndoTheia, Inc.

EndoTheia has developed a groundbreaking technology that radically improves minimally invasive endoscopic surgery. This technology harnesses the power of intelligently micro-machined smart materials to create highly dexterous manipulators at millimeter and sub-millimeter scales to improve therapeutic outcomes in complex flexible endoscopic procedures. This patented technology was developed by EndoTheia’s founders at Vanderbilt University and the University of Tennessee, Knoxville, with funding from the National Institutes of Health. For additional information about EndoTheia and the FDA Breakthrough Device designation, visit www.endotheia.com.

Female Pelvic Health Expert Renee M. Caputo, M.D., Joins Central Ohio Urology Group

Central Ohio Urology Group is pleased to announce that Renee M. Caputo, M.D., has joined its care team. Dr. Caputo is a gynecologist by training and has been a full-service female pelvic health specialist in the Columbus area for three decades. Central Ohio Urology Group is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and related specialty services in the nation, which is backed by NMS Capital.

With a clinical network of 15 offices in the region, Central Ohio Urology Group is a leading provider of comprehensive urological services, including general urology, men’s health, women’s health, cancer care, advanced cancer treatment and radiation oncology. Central Ohio Urology Surgery Center is one of the first ambulatory surgery centers in the country to offer urologic robotic surgery.

Corina Tracy, Chief Executive Officer of U.S. Urology Partners, the parent company of Central Ohio Urology Group, stated, “We are honored to welcome such a highly respected physician as Dr. Renee Caputo to the care team at Central Ohio Urology Group. Dr. Caputo’s years of experience and fellowship training in urogynecology and female pelvic medicine further expand our level of care and innovative treatments for women with pelvic health issues. Dr. Caputo will help us deliver our mission of providing an individualized, high-quality and compassionate experience for every person we are honored to serve.”

Born and raised in Ohio, Dr. Caputo has extensive experience in pelvic health and treats female (biologic) patients. She attended a 6-year combined BS/MD program at Kent State University and Northeastern Ohio Universities College of Medicine (now called NEOMED). Dr. Caputo completed her residency in Obstetrics and Gynecology at The University of Pittsburgh/Magee Women’s Hospital and then went on to complete a fellowship in Urogynecology and Female Pelvic Medicine at Methodist Hospital of Indiana in Indianapolis.

Dr. Caputo serves female patients with pelvic health issues, including urinary and fecal incontinence, urinary and defecatory voiding dysfunction, recurrent urinary tract infections (UTIs), pelvic organ prolapse, pelvic floor muscle dysfunction including pain, painful bladder syndrome, vulvar pain and skin disorders, dyspareunia and overactive bladder.

Dr. Caputo stated, “I am excited to join Central Ohio Urology Group’s dedicated, highly skilled care team. The Central Ohio Urology Group facilities that I will work from will seamlessly support my 30 year old practice and enable me to continue providing the high quality that I strive to achieve.”

“Patient care for me is simple: take the time to listen to the patient’s concerns and individualize care to address those concerns in the most efficient, least invasive and least costly way possible,” said Dr. Caputo. “I believe that every woman with pelvic floor dysfunction is entitled to a comfortable and professional healthcare encounter that will improve her quality of life, educate her and thus empower her to maintain pelvic floor health throughout her lifetime.”

“Patients appreciate the time I take with them, the fact that I listen to them and take their concerns seriously, that I involve them in the decision making, that their concerns are addressed in a timely manner and that if I can’t address their concern(s) personally, I will find them the person/service that can. More concisely, I believe that patients consider me to be their advocate,” added Dr. Caputo.

To learn more about Dr. Renee Caputo or to schedule an appointment with the Central Ohio Urology Group care team, please visit www.centralohiourology.com or call (614) 396-2684.

Virtuoso Surgical Announces First Public Offering of Common Stock to Advance its Revolutionary Robotic System for Endoscopic Surgery

Virtuoso Surgical, Inc., a Nashville-based medical device company, announced today that its $20 million stock offering has become effective after review by the United States Securities and Exchange Commission and the Financial Industry Regulatory Authority.

Virtuoso Surgical has developed a robotic surgery system that radically improves minimally invasive endoscopic surgery. Virtuoso uses patented technology developed by the Company’s founders at Johns Hopkins University and Vanderbilt University with funding from the National Science Foundation and the National Institutes of Health.

Virtuoso Surgical’s offering is made under SEC Regulation A, Tier 2, which means that any U.S. person can invest in the Company. The offering is for the sale of common stock, and this is the first offering of the Company’s common stock to the public.

“Virtuoso Surgical was founded to make minimally invasive surgery more effective by providing surgeons with dexterous, accurate and cost-effective tools for endoscopic surgery,” stated Robert J. Webster, III, PhD, Co-Founder and President. “We are not aware of any technology that accomplishes the dexterity, precision and force of the Virtuoso Surgical device, at such a small diameter. It enables surgeons to use two hands to perform more accurate interventions deep in the body through endoscopes.”

Duke Herrell, III, MD, FACS, Co-Founder, Interim CEO and Chief Medical Officer of Virtuoso Surgical, added, “We are excited about the opportunity to sell our common stock to the public. We expect to complete the design of our system by the end of this year, and to conduct final testing of the system in 2023. The capital that we will raise through this offering of common stock will, we believe, propel our system through final design, testing and FDA approval for sale in the United States.”

Virtuoso Surgical’s team of internationally recognized clinical and engineering experts includes Dr. Webster and Dr. Herrell, along with Richard Hendrick, PhD, Chief Operating Officer. Drs. Webster and Herrell, along with others, co-founded the Vanderbilt Institute for Surgery and Engineering (VISE), and Dr. Hendrick has been the lead engineer for Virtuoso since it began operations in 2017.

The Virtuoso Surgical system has demonstrated feasibility in animal, cadaver and tissue model studies in surgeries for bladder cancer, uterine fibroids (among other intrauterine procedures), enlarged prostate (benign prostatic hyperplasia – BPH), central airway obstruction removal, and endoscopic neurosurgery.

The technology can provide dexterity in any procedures where tools are delivered through rigid endoscopes, including urology, gynecology, neurology, interventional pulmonology, orthopedics, thoracic surgery, ear, nose and throat (ENT) and other sub-specialties.

Virtuoso Surgical Resources

Videos of Several First Surgeries

Academic Publications

Articles

About Virtuoso Surgical

Virtuoso Surgical has developed a groundbreaking robotic surgery system that radically improves minimally invasive endoscopic surgery. The Virtuoso Surgical system features a pair of instrument delivery arms made of concentric nitinol tools that mimic a surgeon’s hands to offer unprecedented control and dexterity to a full range of endoscopic applications. The system uses patented technology developed by Virtuoso’s founders at Johns Hopkins University and Vanderbilt University with funding from the National Science Foundation and the National Institutes of Health. For additional information about Virtuoso Surgical and the initial public offering of common stock, visit www.virtuososurgical.net and www.virtuososurgical.net/investors.

Colin P. Ryan, M.D., Joins Central Ohio Urology Group

Colin P. Ryan, M.D., has joined the care team of Central Ohio Urology Group, one of the nation’s leading providers of comprehensive urological services with a network of 15 offices in the region.

Central Ohio Urology Group offers more than 50 specialties and subspecialties within general urology, men’s health, women’s health, cancer care, advanced cancer treatment and radiation oncology. Central Ohio Urology Surgery Center is one of the first urological ambulatory surgery centers in the country to provide robotic surgery.

Corina Tracy, Chief Executive Officer of U.S. Urology Partners, the parent company of Central Ohio Urology Group, stated, “We are pleased to welcome Dr. Colin Ryan to the care team at Central Ohio Urology Group. Dr. Ryan’s approach mirrors our core purpose to provide an individualized, high-quality and compassionate patient experience for every person we are honored to serve. Dr. Ryan will help us continue to offer the most advanced treatments for patients with issues such as overactive bladder, incontinence, pelvic organ prolapse and recurrent urinary tract infections, and further strengthen Central Ohio Urology Group as a hub of multidisciplinary care for complex pelvic medicine disorders.”

Born and raised just outside of Cleveland, Dr. Ryan developed his interest in medicine as a high school biology student. He attended Georgetown University where he studied Human Science. He received his medical doctorate degree from The Ohio State University College of Medicine. Dr. Ryan completed his Urology Residency and General Surgery internship at SUNY Stony Brook University Hospital where he developed his interest in General and Female Urology.

Dr. Ryan said, “I feel at home with the staff at Central Ohio Urology Group, who I know work hard to ensure the best care for patients. Completing residency on the East Coast broadened my worldview and exposed me to the underserved population that is pelvic medicine patients. Treatment of pelvic floor disorders and urinary incontinence is rapidly evolving, and Central Ohio Urology Group provides me with state-of-the-art technologies and support staff to bring these innovative technologies to patients in the region.”

“Urinary incontinence, overactive bladder and other pelvic medicine conditions affecting urination are suffered with silently by both men and women. I strive to educate my patients and provide them with treatments that can improve not only the condition, but also their quality of life. There is no one-size-fits-all therapy for most chronic urinary disorders, which makes listening to my patients and incorporating their goals into my therapies the cornerstone of how I practice medicine,” said Dr. Ryan.

Dr. Ryan added, “Listening to my patients’ concerns to make a patient-centered treatment plan is my key to providing quality care. I strive to explain medical conditions and their treatments in ways that my patients can understand and discuss with their loved ones. Utilizing both medical therapy and procedures ranging from minimally invasive to open surgery offers me the latitude to provide necessary therapy in a patient’s best interest.”

To learn more about Dr. Colin P. Ryan or to schedule an appointment with the Central Ohio Urology Group care team, please visit www.centralohiourology.com or call (614) 396-2684.

About Central Ohio Urology Group

Central Ohio Urology Group is one of the nation’s leading providers of urological services with a network of 15 offices in the region. Headquartered just outside of Columbus in Gahanna, Ohio, Central Ohio Urology Group provides comprehensive services, including general urology, men’s health, women’s health, cancer care, advanced cancer treatment and radiation oncology. Facilities in the Columbus area include an Advanced Prostate Cancer Clinic, as well as the state-of-the-art Central Ohio Urology Surgery Center that is one of the first ambulatory surgery centers in the country to offer roboticsurgery. Central Ohio Urology Group’s experienced care team provides more than 50 urological specialties and subspecialties. Central Ohio Urology Group is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and related specialty services in the nation, which is backed by NMS Capital. For more information, visit www.centralohiourology.com and www.us-uro.com.

Kerry Massey Joins U.S. Urology Partners as Chief Financial Officer

U.S. Urology Partners today announced that Kerry D. Massey, CPA, a results-driven financial leader with nearly three decades of experience, has joined the company as Chief Financial Officer. U.S. Urology Partners is one of the nation’s largest independent providers of urological and related specialty services, including general urology, surgical procedures, advanced cancer treatment and other ancillary services.

The rapidly growing U.S. Urology Partners clinical network now consists of more than 40 locations throughout the East Coast and Midwest. U.S. Urology Partners partnered with NMS Capital in 2018 to support urology practices in communities across the country.

Corina Tracy, Chief Executive Officer of U.S. Urology Partners, stated, “We are excited to welcome Kerry Massey as Chief Financial Officer of U.S. Urology Partners. Kerry’s years of experience leading multi-location healthcare organizations will be a tremendous asset to U.S. Urology Partners’ growing network. His expertise will help us deliver on our core purpose of providing the highest level of urological care to every person we are honored to serve and fulfill our ambition of uniting high-performing, growth-oriented physician practices to provide the most effective, efficient and innovative urologic care to the people in  the many communities that we serve.”

Kerry D. Massey, CPA, Chief Financial Officer of U.S. Urology Partners, stated, “I am honored to join U.S. Urology Partners and impressed with the team’s commitment to provide high-quality healthcare services with compassion and care. U.S. Urology Partners supports physician leaders and their care teams with the business aspects of their practices, enabling them to focus on patient care and driving optimal outcomes. I look forward to further developing and scaling U.S. Urology Partners to improve access to essential urological services, while setting the standard of care in communities across the country.”

About Kerry D. Massey, CPA

Kerry D. Massey, CPA, is a financial leader with nearly three decades of professional experience and more than 10 years in senior leadership roles in healthcare finance. He has extensive expertise and success in driving organizational growth and positive change through strategic planning, mergers and acquisitions, reorganization and process improvement. Massey’s background encompasses private equity and SEC companies as well as oversight of multi-locations/business units.

Prior to joining U.S. Urology Partners as Chief Financial Officer, Massey was Executive Vice President and Chief Financial Officer of Diversicare, a post-acute and long-term care provider with 61 skilled nursing centers across eight states. He previously served as Vice President and Corporate Controller for a private equity backed healthcare provider with 155 clinical locations in 31 states, as well as 3M, which formerly was M*Modal, MedQuist and Spheris, a global outsourced healthcare technology solutions provider.

A big four public accounting alum, Massey spent the early portion of his career with Arthur Andersen LLP and Ernst & Young LLP in addition to a period with KraftCPAs PLLC, a Tennessee based certified public accounting firm. Massey received his BBA in Finance from the University of Memphis and also completed graduate level courses in Accounting on his path to becoming a certified public accountant licensed in Tennessee.

About U.S. Urology Partners

U.S. Urology Partners is one of the nation’s largest independent providers of urology and related specialty services, including general urology, surgical procedures, advanced cancer treatment and other ancillary services. The U.S. Urology Partners clinical network consists of more than 40 locations throughout the East Coast and Midwest, including affiliate practices Central Ohio Urology Group, Associated Medical Professionals of NY and Florida Urology Center. U.S. Urology Partners was formed to support urology practices with an experienced team of healthcare executives and resources, and is backed by NMS Capital. The U.S. Urology Partners corporate office is in Nolensville, Tennessee, just outside of Nashville. For additional information about U.S. Urology Partners, please visit www.us-uro.com.

Florida Urology Center Joins Forces with U.S. Urology Partners

U.S. Urology Partners announced today its strategic partnership with Florida Urology Center, a full-service specialty group which has set the standard of care in the region for three decades. Florida Urology Center provides comprehensive services in five locations throughout Florida, including Ormond Beach, Port Orange, Orange City, New Smyrna Beach and Palm Coast.

U.S. Urology Partners is one of the nation’s largest independent providers of urological and related specialty services, including general urology, surgical procedures, advanced cancer treatment and other ancillary services. The rapidly growing U.S. Urology Partners clinical network now consists of more than 40 locations throughout the East Coast and Midwest. U.S. Urology Partners partnered with NMS Capital in 2018 to support urology practices in communities across the country.

Corina Tracy, Chief Executive Officer of U.S. Urology Partners, stated, “We are honored to welcome Florida Urology Center, which is well-known for its quality care and advanced technology, including a state-of-the-art surgery center. The addition of Florida Urology Center expands our multi-regional clinical network, which now spans the East Coast and the Midwest. Through collaboration among our partner practices, we are able to make an even greater impact on delivering the highest level of urological care in the communities we serve.”

Greg A. Parr, M.D., of Florida Urology Center stated, “We are pleased to join U.S. Urology Partners and share a common dedication to providing the highest quality of comprehensive urological care. Our partnership with U.S. Urology Partners will enable us to continue improving the lives of patients by offering the most current diagnostic and therapeutic alternatives available in the region and investing in the latest technologies. Through the support provided by U.S. Urology Partners to our growing practice, the Florida Urology Center care team can remain focused on our most important priority—our patients.”

U.S. Urology Partners assists urology practices through an experienced team of healthcare executives and resources. The practices benefit from U.S. Urology Partners’ substantial investment in people, technology and services to better address patient and employee needs in the communities they serve, while being well positioned for continued growth.

About U.S. Urology Partners

U.S. Urology Partners is one of the nation’s largest independent providers of urology and related specialty services, including general urology, surgical procedures, advanced cancer treatment and other ancillary services. The U.S. Urology Partners clinical network consists of more than 40 locations throughout the East Coast and Midwest. U.S. Urology Partners was formed to support urology practices with an experienced team of healthcare executives and resources, and is backed by NMS Capital. The U.S. Urology Partners corporate office is in Nolensville, Tennessee, just outside of Nashville. For additional information about U.S. Urology Partners, please visit www.us-uro.com.

 About Florida Urology Center

Established in 1992, Florida Urology Center has five convenient locations throughout Florida, including Ormond Beach, Port Orange, Orange City, New Smyrna Beach and Palm Coast. Florida Urology Center is committed to providing quality healthcare to its patients through education, training, clinical research, and support. The practice is dedicated to improving the lives of its patients by offering the most current diagnostic and therapeutic alternatives available. Facilities are equipped with the latest state-of-the art technology to provide the safest and most comprehensive care. Most of the surgeries are performed in Florida Urology Center’s outpatient surgery center licensed by the state of Florida and certified by Medicare. For more information about Florida Urology Center, please visit www.floridaurology.com.

Nationally Recognized Urological Expert Dr. T.J. Tausch Joins Central Ohio Urology Group

Central Ohio Urology Group is pleased to announce that Timothy “T.J.” Tausch, M.D., M.S., M.B.A. has joined its care team. Dr. Tausch joins Central Ohio Urology Group from Walter Reed National Military Medical Center, where he was Director of Trauma, Reconstructive and Prosthetic Urology, Residency Program Director and Urology Consultant to the White House.

With a clinical network of 15 offices in the region, Central Ohio Urology Group is one of the nation’s leading providers of comprehensive urological services, including general urology, men’s health, women’s health, cancer care, advanced cancer treatment and radiation oncology. Central Ohio Urology Surgery Center is one of the first ambulatory surgery centers in the country to offer robotic surgery.

Corina Tracy, Chief Executive Officer of U.S. Urology Partners, the parent company of Central Ohio Urology Group, stated, “We are honored to welcome Dr. T.J. Tausch to our urological care team. Dr. Tausch’s fellowship training and extensive experience in trauma, reconstructive and prosthetic urology provides us with leading edge insight into the most advanced, effective treatments available. His expertise will help us continue to expand our level of care, improving the quality of life of people in the communities we serve.”

Born and raised in Wayne County, Dr. Tausch returns to Ohio following 15 years on active duty in the United States Army. After graduating from the University of Notre Dame, Dr. Tausch attended medical school at Case Western Reserve University, where he received a dual M.D./M.S. degree in applied anatomy. Dr. Tausch completed his General Surgery Residency (Pre-Urology) and Urology Residency at Madigan Army Medical Center in Tacoma, Washington. He further specialized in Trauma, Reconstructive and Prosthetic Urology with a fellowship at University of Texas Southwestern Medical Center in Dallas. Dr. Tausch also earned an M.B.A. from the George Washington University School of Business.

Dr. Tausch said, “I am excited to be back in Ohio, where I was born and raised. My practice focuses on helping people with urologic problems – repairing issues caused by side effects of cancer treatment, urologic trauma, surgical complications and general effects of aging. With my arrival, Central Ohio Urology Group will now be able to offer state-of-the-art reconstructive options for all urology patients.”

“I often tell my patients, ‘I might not be the surgeon who saves your life, but I promise to do everything I can to make it better.’ I look forward to bringing my training and expertise to patients in Ohio, and doing my best to help those with urologic problems maximize their quality of life,” added Dr. Tausch.

To learn more about Dr. T.J. Tausch or to schedule an appointment with the Central Ohio Urology Group care team, please visit www.centralohiourology.com or call (614) 396-2684.

About Central Ohio Urology Group

Central Ohio Urology Group is one of the nation’s leading providers of urological services with a network of 15 offices in the region. Headquartered just outside of Columbus in Gahanna, Ohio, Central Ohio Urology Group provides comprehensive services, including general urology, men’s health, women’s health, cancer care, advanced cancer treatment and radiation oncology. Facilities in the Columbus area include an Advanced Prostate Cancer Clinic, as well as the state-of-the-art Central Ohio Urology Surgery Center that is one of the first ambulatory surgery centers in the country to offer robotic surgery. Central Ohio Urology Group’s experienced care team provides more than 50 urological specialties and subspecialties. Central Ohio Urology Group is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and related specialty services in the nation, which is backed by NMS Capital. For more information, visit www.centralohiourology.com and www.us-uro.com.

U.S. Urology Partners Adds Mandy Lawrence and Corrinne Ehlert to C-Suite

Experienced Health Executives Fill Roles of Chief Operating Officer and Chief Compliance Officer

U.S. Urology Partners, one of the country’s largest independent providers of urology and related specialty services, today announced the addition of two nationally recognized healthcare leaders to its senior executive team. Mandy Lawrence has joined the rapidly growing business as Chief Operating Officer, and Corrinne Ehlert has been named Chief Compliance Officer.

U.S. Urology Partners was formed to support urology practices with an experienced team of healthcare executives and resources, and is backed by NMS Capital. The U.S. Urology Partners clinical network now consists of 24 offices spanning the Midwest and Northeast. Given the interest in U.S. Urology Partners’ unique model of supporting practices, discussions are underway with numerous groups regarding partnership opportunities.

Corina Tracy, Chief Executive Officer of U.S. Urology Partners, stated, “We are very pleased to welcome Mandy Lawrence and Corrinne Ehlert to the U.S. Urology Partners team. Their decades of experience in healthcare operations and backgrounds in providing outstanding clinical care will be invaluable as we continue to enhance the urological services in the communities we serve. In addition to sharing best practices and team efficiencies,  Mandy and Corrinne will play a critical role as we expand our geographic footprint.”

Mandy Lawrence, Chief Operating Officer

Lawrence an experienced multi-site healthcare operational leader who has distinguished herself throughout her career. With a nursing degree and MBA, she possesses a unique balance of operational expertise and clinical leadership. Before joining U.S. Urology Partners, Lawrence was Division Vice President at Center for Autism and Related Disorders, managing the East Division comprised of 20 states. Lawrence previously served as Regional Vice President of Operations for Compassus. During her tenure, her region was recognized as a leader in growth, profitability and quality.

Lawrence received a Bachelor of Arts degree in biology from William Woods University and earned her Bachelor of Science in nursing from the University of Missouri at Columbia. Lawrence returned to William Woods University for her graduate work, where she was awarded an MBA with healthcare administration emphasis.

Corrinne Ehlert, Chief Compliance Officer

Ehlert is responsible for the development and execution of U.S. Urology Partners’ Compliance Program. Ehlert is an experienced healthcare leader with three decades of proven success in performance and outcomes. She brings broad and deep expertise as a healthcare services professional focused on organizational leadership, compliance, and clinical and operational excellence. Ehlert joins U.S. Urology Partners from Three Oaks Hospice, a private equity-backed company with multi-state operations, where she led Compliance, Quality and Clinical Operations. She previously served at Alive Hospice as Vice President of Operational Improvement and Compliance.

Ehlert holds a bachelor’s degree in healthcare administration from St. Joseph’s College in Maine and an associate degree in nursing from University of Nevada Las Vegas.

About U.S. Urology Partners

U.S. Urology Partners is one of the nation’s largest independent providers of urology and related specialty services, including general urology, surgical procedures, advanced cancer treatment and other ancillary services. The U.S. Urology Partners practice continues to grow rapidly and currently consists of a network of 24 offices throughout the Midwest and Northeast. U.S. Urology Partners was formed to support urology practices with an experienced team of healthcare executives and resources, while serving as a platform upon which NMS Capital is building a leading provider of urological services. The U.S. Urology Partners corporate office is in Nolensville, Tennessee, just outside of Nashville. For additional information, please visit the U.S. Urology Partners website at www.us-uro.com.